Report updated Apr 24, 2026

Overview · Full Intel report in progress

BreatheSmart is an established medical app that is completely free. With a 4.5/5 rating from 31 reviews, it shows polarized user reception.

What is BreatheSmart?

BreatheSmart is a medical companion app developed by Voluntis designed to assist users in managing respiratory conditions like asthma and COPD. The platform integrates symptom tracking, medication reminders, and smart device connectivity to provide data-driven insights and clinical reporting.

Current Momentum

v3.12 · 3mo ago

Steady

Last updated 92d ago. 5 versions tracked.

AI-powered deep analysis surfacing high-signal insights. Still in beta, accuracy improves daily. For informational purposes only.

Competition

Rivals identification in progress

7-Day Rank Pulse 🇺🇸

Medical

No ranking data

MedicalGrossing

Rating Pulse 🇺🇸

What makes this app unique?

What Does It Look Like?

How Is The App's Momentum Right Now?

Loading...

What Are The Key Features?

Symptom & Trigger TrackingStandard

Monitors respiratory symptoms and environmental triggers like air quality to identify patterns and treatment effectiveness.

Medication ManagementStandard

Provides timely reminders to help users maintain consistent medication schedules.

Device InterconnectionStandard

Syncs data from smart inhaler sensors and peak flow meters to offer personalized inhalation technique feedback.

Clinical ReportingStandard

Generates PDF reports of health data to facilitate communication between patients and their medical teams.

How much does it cost?

Free

Who Built It?

Voluntis

(64.8K)

Providing digital therapeutic companions for chronic condition management and clinical reporting.

Portfolio

4

Apps

Free 3
Medical100%

Who is Voluntis?

Voluntis operates in the digital therapeutics space, focusing on chronic condition management through patient-facing tracking tools that bridge the gap between daily symptoms and clinical consultations. Their primary advantage is the integration of specialized medical reporting and community-driven data, particularly within the migraine niche where they have established a dominant user base. While Migraine Buddy remains their flagship, the publisher is diversifying into other high-stakes chronic areas like Multiple Sclerosis and respiratory health, signaling a move toward a broader platform for multi-condition management.

Who is Voluntis for?

  • Patients managing chronic conditions such as migraines
  • Asthma
  • MS who require structured symptom logging for personal insights or clinical review
Intense

Portfolio momentum

Maintained an intense development pace with 21 updates across 4 active apps in the last 6 months, with the most recent release occurring 9 days ago.

Last release · 9d agoActive apps · 4

Analysis in progress, available soon

What do users think recently?

Analysis in progress, available soon

Analysis in progress, available soon

What is the competitive landscape for BreatheSmart?

How's The Medical Market?

Market outlook for this category

Available very soon

Strategic analysis coming soon

SWOT, key takeaways & outlook

The outtake for BreatheSmart

Key Takeaways

BreatheSmart functions as a comprehensive digital health tool that bridges the gap between daily symptom management and clinical data sharing.

Where Is It Heading?

Trend analysis

Available very soon

Disclosure

Independent intel to help builders create better apps.

AI-powered analysis with editorial review, built from publicly available sources. See methodology.

Marlvel.ai is not affiliated with, endorsed by, or sponsored by BreatheSmart, its developer, the app publisher, Apple, or Google Play. All trademarks, logos, and screenshots referenced remain the property of their respective owners.

Hope this helps & keep building! · Found an error?

What's new in this report

No changes detected yet.

Cite this report

Marlvel.ai. “BreatheSmart Intelligence Report.” Updated Apr 24, 2026. https://marlvel.ai/intel-report/medical/breathesmart

Agent Markdown (.md)·

Data licensed under CC-BY-NC 4.0